Warner Chilcott faces challenge to new contraceptive; Daiichi wins FDA nod for Walchol variant;

@FiercePharma: Will pharma fight the Express-Medco deal? Piece | Follow @FiercePharma

> India's Lupin asked FDA to approve its version of the brand-new Warner Chilcott contraceptive Lo Loestrin FE; the branded drugmaker expects to sue for patent infringment. Report

> Japanese drugmaker Daiichi Sankyo won FDA approval for a new version of its diabetes drug Welchol. Now, the drug can be mixed with fruit juice or diet soda. Report

> Eli Lilly ($LLY) ranked 28th among top charitable givers in a survey of the 300 largest public companies in the U.S. Report

> Biogen Idec's ($BIIB) Fampyra drug for multiple sclerosis patients, launched in the U.S. last year, won conditional approval from European regulators. Report

> AstraZeneca ($AZN) bought back more than 140,000 of its own shares for cancellation, at a price of 3054 pence per share. Report

> FDA earmarked $700,000 to back research into improving the quality of pharmaceutical manufacturing. Report

Biotech News

@FierceBiotech: Nonprofit poised to reap rewards from Vertex's pioneering CF drug. Article | Follow @FierceBiotech

@JohnCFierce: Under pressure to speed things up, FDA Commissioner Margaret Hamburg is looking to loosen conflict rules for adcomm members. Report | Follow @JohnCFierce

@RyanMFierce: Icon's buyout of clinical tech firm Firecrest motivated by improving trials time lines, efficiency. Story | Follow @RyanMFierce

> GlaxoSmithKline relying on Ph3 strategy in R&D comeback bid. News

> Takeda heads back to FDA with diabetes blockbuster hopeful. Item

Manufacturing News

> Fictional "Spenditol" gives appearance of feelings of relief, unpleasant side effects. Piece

> Rx-360 concludes pilot; begins sharing of supplier audits. News

> For J&J/McNeil no exec blame for recalls,panel says. Report

> Novartis productivity boss seeks procurement's full potential. Article

> Teva supply chain gets a boost from social media. Story

> Hong Kong tips off Vietnam about contaminated GSK drug. More

Biotech Research News

> Researchers detract last year's discovery of longevity genes. Article

> Enzyme insights could lead to better sunburn treatments. Story

> Genetic map of American Americans gives clues to diseases in all populations. Report

> UK scientists urge regulations of animal/human gene experiments. Item

And Finally... Dialysis provider DaVita has been sued by whistleblowers alleging that it defrauded Medicare by overbilling for prescription drugs. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.